Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 23 January, 2015
M:Moderate-Quality Evidence
By
vgreene
, 23 January, 2015
H:High-Quality Evidence
By
vgreene
, 23 January, 2015
W:Weak Recommendation
By
vgreene
, 23 January, 2015
S:Strong Recommendation
By
vgreene
, 23 January, 2015
IDSA
By
vgreene
, 23 January, 2015
Oral abx x 7 days:
By
vgreene
, 23 January, 2015
Erythromycin<sup>6</sup> 250 mg PO qid [S/H]
By
vgreene
, 23 January, 2015
Penicillin VK<sup>6</sup> 250-500 mg PO qid [S/H]
By
vgreene
, 23 January, 2015
TMP/SMX<sup>4</sup> 1-2 DS PO bid [S/M]
By
vgreene
, 23 January, 2015
Clindamycin<sup>4,5</sup> 300-450 mg PO qid [S/M]
Pagination
First page
Previous page
…
Page
3977
Page
3978
Page
3979
Page
3980
Current page
3981
Page
3982
Page
3983
Page
3984
Page
3985
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube